Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects

Diabetes Research and Clinical Practice

Volumn 69, Issue 2, 2005, Pages 180-187

  Hahn, Wook Kang ^a   Dong, Joon Kim ^b   Lee, Myung Shik ^c   Kim, Kwang Won ^c   Lee, Moon Kyu ^c  

^a Department of Internal Medicine   (South Korea)

^b Inje University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Diabetes mellitus; Homeostasis model assessment of insulin resistance; Impaired fasting glucose; Impaired glucose tolerance; Insulinogenic index; Obesity

Indexed keywords

GLUCOSE; INSULIN;

ADULT; BODY MASS; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC HETEROGENEITY; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HEALTH PROMOTION; HOMEOSTASIS; HUMANS; KOREA; MIDDLE AGED; OBESITY;

EID: 21744432178     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.12.011     Document Type: Conference Paper

References (34)

1. S. Del Prato, P. Marchetti, and R.C. Bonadonna Phasic insulin release and metabolic regulation in type 2 diabetes Diabetes 51 Suppl. 2002 S109 S116
2. B.C. Martin, J.H. Warram, A.S. Krolewski, R.N. Bergman, J.S. Soeldner, and C.R. Kahn Role of glucose and insulin resistance in development of type 2 diabetes: result of a 25-year follow-up study Lancet 340 1992 925 929
3. S.E. Kahn The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiologic of type 2 diabetes Diabetologia 46 2003 3 19
4. S. Lillioja S, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, and E. Ravussin Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 1988 1992
5. C. Weyer, P.A. Tataranni, C. Bogardus, and R.E. Pratley Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development Diabetes Care 24 2001 89 94
6. S.M. Haffner, H. Miettinen, S.P. Gsaskill, and M.P. Stern Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance Diabetologia 39 1996 1201 1207
7. M.M. Garb, R.L. Hanson, D. Dabelea, G. Imperatore, J. Roumain, and P.H. Bennettt The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes Diabetes Care 23 2000 1108 1112
8. O. Vaccaro, G. Ruffa, G. Imperatore, V. Iovino, A.A. Riveilese, and G. Riccardi Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis Diabetes Care 22 1999 1490 1493
9. S.L. Edeltstein, W.C. Knowler, R.P. Bain, R. Andres, E.L. Barrett-Connor, and G.K. Dowse Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies Diabetes 46 1997 701 710
10. J.B. Meigs, D.C. Muller, D.M. Nathan, D.R. Blake, and R. Andres The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging Diabetes 52 2003 1475 1484
11. N. Unwin, J. Shaw, P. Zimmet, and M. Alberti Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention Diabetic Med. 19 2002 708 723
12. M. Coutinho, H.C. Gerstein, Y. Wang, and S. Yusuf The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240
13. The ECODE Study Group, Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria, Lancet 354 (1999) 616-621.
14. Decode Study Group, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria, Arch. Intern. Med. 161 (2001) 397-405.
15. R.A. DeFronzo, R.C. Bonadonna, and E. Ferrannini Pathogenesis of NIDDM: a balance overview Diabetes Care 15 1992 318 368
16. S. Lillioja Impaired glucose tolerance in Pima Indians Diabetes 40 1991 166 180
17. R.J. Heine, G. Nijpels, and J.M. Mooy New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors Diabetic Med. 13 Suppl. 1995 S12 S14
18. K.W. Chen, D.J. Boyko, R.E. Bergstrom, D.L. Leonetti, L. Newell-Morris, and P.W. Wahl Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM Diabetes Care 18 1995 747 753
19. M.J. Davies, G. Rayman, A. Grenfell, I.P. Gray, J.L. Day, and C.N. Hales Loss of first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance Diabetic Med. 11 1994 432 436
20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 26 (Suppl.) (2003) S5-S20.
21. World Health Organization Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications, Report of a WHO consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, 1999.
22. H. Yoneda, H. Ikegami, Y. Yamamoto, E. Yamato, T. Cha, and Y. Kawaguchi Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance Diabetes Care 15 1992 1517 1521
23. D.I. Phillips, P.M. Clark, C.N. Hales, and C. Osmond Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion Diabetic Med. 11 1993 286 292
24. K. Kosaka, R. Hagura, and T. Kuzuya Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes Diabetes 26 1997 944 952
25. D.-J. Kim, M.-S. Lee, K.-W. Kim, and M.-K. Lee Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus Metabolism 50 2001 590 593
26. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
27. J. Radziuk Insulin sensitivity and its measurement: structural commonalities among the methods J. Clin. Endocrinol. Metab. 5 2000 4426 4433
28. K.J. Mather, A.E. Hunt, H.O. Steinberg, G. Paradisi, G. Hook, and A. Katz Repeatability characteristics of simple indices of insulin resistance: implications for research applications J. Clin. Endocrinol. Metab. 86 2001 5457 5464
29. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431
30. B. Goke Implication of blood glucose, insulin resistance and b-cell function in impaired glucose tolerance Diabetes Res. Clin. Pract. 40 Suppl. 1998 S15 S20
31. K. George, and M. Alberti Impaired glucose tolerance: what are the clinical implications? Diabetes Res. Clin. Pract. 40 Suppl. 1998 S3 S8
32. T.H. Lee Prevalence of obesity in Korean non-insulin dependent diabetic patients Diabetes Res. Clin. Pract. 32 1996 71 90
33. C.S. Shin, H.K. Lee, C.S. Koh, Y.I. Kim, Y.S. Shin, and K.Y. Yoo Risk factors for the development of NIDDM in Younchon county, Korea Diabetes Care 20 1997 1842 1846
34. M. Stumvoll, A. Mitrakou, W. Pimenta, T. Jenssen, H. Yki-Jarvinen, and T. Van Haeften Use of the oral glucose tolerance test to assess insulin resistance and insulin sensitivity Diabetes Care 23 2000 295 301